Skip to main content
. 2020 Mar 6;10(3):477. doi: 10.3390/nano10030477

Figure 11.

Figure 11

Figure 11

Evaluation of anticancer efficacy of Sali-IONPs compared to the free salinomycin on a BBB-brain tumor model in vitro: (a) Sali-IONPs permeability across the bEnd.3 monolayer with or without magnet and mannitol; (b) cytotoxicity of each formulation on U251 cells after penetrating the bEnd.3 monolayer. Note: * indicates a significant difference at p < 0.05 with the other treated groups. Data was presented as mean ± SD; n = 3.